When your child is facing a nutritional, gastrointestinal, or liver problem, Kentucky Children’s Hospital’s division of Pediatric Gastroenterology, Hepatology and Nutrition has the expertise you need for peace of mind.

Gastroenterology Specialties

Our team is here to guide your child and your family through every facet of care, from diagnosis through recovery. We are skilled at diagnosing and treating diseases of the gastrointestinal tract and liver, including:

  • Abdominal pain
  • Acute/chronic liver disease
  • Allergic disorders of the gastrointestinal tract
  • Celiac disease
  • Chronic diarrhea
  • Constipation
  • Crohn’s disease
  • Dysphagia/swallowing disorders
  • Encopresis
  • Eosinophilic esophagitis
  • Esophageal stricture
  • Fatty liver disease
  • Functional gastrointestinal disease
  • Gallbladder disease
  • Gastrointestinal bleeding
  • Gastroparesis
  • Hepatitis (acute and chronic)
  • Inflammatory bowel disease
  • Intestinal polyps
  • Malnutrition (including failure to thrive)
  • Nutritional disorders
  • Pancreatitis (acute and chronic)
  • Peptic ulcer disease
  • Poor weight gain
  • Reflux/heartburn
  • Short bowel syndrome
  • Ulcerative colitis
  • Vomiting

Treatment for these conditions may involve a variety of therapies and often includes specialized care from a dietitian. Our dietitians are highly involved in patient care, even if dietary changes are not the only form of treatment your child needs.

Specialty Clinics and Programs

Our years of expertise have allowed us to develop specialty clinics and programs in many areas of gastrointestinal and liver disease. These programs include our Children’s Aero-digestive Team and Services (UK CATS), Eosinophilic Esophagitis (EOE) Clinic, ImproveCareNow (an inflammatory bowel disease consortium), and Inflammatory Bowel Disease Transition Clinic.

In addition to these programs, we also maintain specialty expertise in diseases of the pancreas, bowel management/constipation, and non-alcoholic fatty liver disease (NAFLD), which is sometimes called obesity-associated liver disease. We’re also involved in clinical trials related to the use of gene therapy to treat phenylketonuria.